News
June 01, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) announced today that the first patient has been dosed in the Phase ... in our CKD trial, marking an important initial step ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback